TY - JOUR
T1 - Nipecotic acid directly activates GABA(A)-like ion channels
AU - Barrett-Jolley, Richard
PY - 2001/7/1
Y1 - 2001/7/1
N2 - The GABA-related compound nipecotic acid is commonly used to inhibit GABA uptake. This report shows that nipecotic acid can also directly activate GABA(A)-like chloride channels. When applied to outside-out patches of paraventricular neurones, nipecotic acid (1 mM) activated inward unitary currents (approximately 3 pA at a holding potential of -60 mV, E(Cl)+44 mV). The EC(50) for ion channel activation was approximately 300 microM, 3 fold greater than that found for GABA itself in this preparation. The nipecotic acid activated channels had similar conductance and kinetic properties to those of GABA activated channels in the same patches, reversed near E(Cl) and were inhibited by bicuculline (3 microM). This study indicates that for experiments in which relatively high concentrations of nipecotic acid are used, possible direct GABA(A) receptor agonist properties should be considered.
AB - The GABA-related compound nipecotic acid is commonly used to inhibit GABA uptake. This report shows that nipecotic acid can also directly activate GABA(A)-like chloride channels. When applied to outside-out patches of paraventricular neurones, nipecotic acid (1 mM) activated inward unitary currents (approximately 3 pA at a holding potential of -60 mV, E(Cl)+44 mV). The EC(50) for ion channel activation was approximately 300 microM, 3 fold greater than that found for GABA itself in this preparation. The nipecotic acid activated channels had similar conductance and kinetic properties to those of GABA activated channels in the same patches, reversed near E(Cl) and were inhibited by bicuculline (3 microM). This study indicates that for experiments in which relatively high concentrations of nipecotic acid are used, possible direct GABA(A) receptor agonist properties should be considered.
U2 - 10.1038/sj.bjp.0704128
DO - 10.1038/sj.bjp.0704128
M3 - Article
C2 - 11429391
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
SN - 1476-5381
VL - 133
SP - 673
EP - 678
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 5
ER -